These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies on new antibiotic lividomycins. V. In vitro and in vivo antimicrobial activity of lividomycin A. Kobayashi F; Nagoya T; Yoshimura Y; Kaneko K; Ogata SI J Antibiot (Tokyo); 1972 Feb; 25(2):128-36. PubMed ID: 4624613 [No Abstract] [Full Text] [Related]
4. [What does the minimal inhibitory concentration of an antibiotic hide from the clinician? Experimental examples]. Gerber AU; Feller-Segessenmann C; Craig WA Schweiz Med Wochenschr; 1983 Jan; 113(2):34-7. PubMed ID: 6402813 [TBL] [Abstract][Full Text] [Related]
6. [Microbial antibiotic resistance testing with special emphasis on gentamicin]. Bischoff P Munch Med Wochenschr; 1971 Mar; 113(10):353-7. PubMed ID: 5205156 [No Abstract] [Full Text] [Related]
7. Evaluation of BL-P1654: a semisynthetic penicillin as a topical ocular therapy. Cagle GD; Schlech BA Cornea; 1984; 3(1):27-32. PubMed ID: 6100241 [TBL] [Abstract][Full Text] [Related]
8. [Effect of gentamicin and other therapeutic drugs on the causative agents in urinary tract infections. 10-year report]. Schmid W Med Welt; 1980 Jan; 31(1):32-6. PubMed ID: 6770223 [No Abstract] [Full Text] [Related]
9. Pharmacologic studies on tobramycin and comparison with gentamicin. Meyers BR; Hirschman SZ J Clin Pharmacol New Drugs; 1972; 12(8):321-4. PubMed ID: 4484032 [No Abstract] [Full Text] [Related]
10. [Data on the effectiveness of a new aminoglycoside antibiotic in the treatment of urinary tract infections]. Trischitta C; Urso G; Caruso L; Calcara G Minerva Urol; 1980; 32(1):49-58. PubMed ID: 7382968 [No Abstract] [Full Text] [Related]
11. Activity and toxicity of bleomycin. Ishizuka M; Takayama H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1967 Jan; 20(1):15-24. PubMed ID: 6072277 [No Abstract] [Full Text] [Related]
13. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics. Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865 [No Abstract] [Full Text] [Related]
14. H107, a new aminoglycoside anti-Pseudomonas antibiotic produced by a new strain of Spirillospora. Hacène H; Daoudi-Hamdad F; Bhatnagar T; Baratti JC; Lefebvre G Microbios; 2000; 102(402):69-77. PubMed ID: 10885497 [TBL] [Abstract][Full Text] [Related]
15. A new antibiotic, josamycin. II. Biological studies. Nitta K; Yano K; Miyamoto F; Hasegawa Y; Sato T J Antibiot (Tokyo); 1967 Jul; 20(3):181-7. PubMed ID: 6072799 [No Abstract] [Full Text] [Related]
16. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
17. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage. Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151 [TBL] [Abstract][Full Text] [Related]
18. Conclusion to be derived from in vitro data with respect to in vivo activity. Gotoh S Clin Ther; 1981; 4 Suppl A():8-17. PubMed ID: 7326694 [TBL] [Abstract][Full Text] [Related]
19. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. Armour AD; Shankowsky HA; Swanson T; Lee J; Tredget EE J Trauma; 2007 Jul; 63(1):164-71. PubMed ID: 17622885 [TBL] [Abstract][Full Text] [Related]